• This Saturday, November 16, you have the chance to ask Tinnitus Quest anything.

    The entire Executive Board, including Dr. Dirk de Ridder and Dr. Hamid Djalilian are taking part.

    The event takes place 7 AM Pacific, 9 AM Central, 10 AM Eastern, 3 PM UK (GMT).

    ➡️ Read More & Register!

Frequency Therapeutics — Hearing Loss Regeneration

As positive as this might be, and I am really hoping it is successful, there could be downsides. What if when the hair cells grow back tinnitus gets 10 x louder? What if some people get tumors? What if...?

Caution must be exercised despite our need for a solution. I would wait for a completed phase 3. As I understand it, phase 1 is a very small sample of people who get a really small dose to see if it has negative effects. If phase one doesn't kill or maim anyone, they go to phase 2. Phase 2 is also only testing for negative effects using a larger test group. If phase 2 also doesn't kill or maim, then they go on to phase 3. Phase 3 is the only phase that tests to see if the drug actually works. So skipping phase 3 may not be in our best interests.

I am not as knowledgeable about this stuff as others here, but this was what I read some time ago about a different drug trial I was following.
 
As positive as this might be, and I am really hoping it is successful, there could be downsides. What if when the hair cells grow back tinnitus gets 10 x louder? What if some people get tumors? What if...?

Caution must be exercised despite our need for a solution. I would wait for a completed phase 3. As I understand it, phase 1 is a very small sample of people who get a really small dose to see if it has negative effects. If phase one doesn't kill or maim anyone, they go to phase 2. Phase 2 is also only testing for negative effects using a larger test group. If phase 2 also doesn't kill or maim, then they go on to phase 3. Phase 3 is the only phase that tests to see if the drug actually works. So skipping phase 3 may not be in our best interests.

I am not as knowledgeable about this stuff as others here, but this was what I read some time ago about a different drug trial I was following.
I believe it was noted in phase 1 that they already experienced positive results in hearing regeneration.

Also, let's just be real here, multi millions of dollars just jumped on board here recently, so I think they feel very strongly about their chances here.
 
I believe it was noted in phase 1 that they already experienced positive results in hearing regeneration.

Also, let's just be real here, multi millions of dollars just jumped on board here recently, so I think they feel very strongly about their chances here.
It could be spin.
 
Raising lots of money and having an ostensibly successful drug in the works is NOT guaranteed to be a success.

AbbVie-Backed Startup Raises $133 Million To Fight Alzheimer's With Immunotherapy

A year later...

AbbVie Discontinued a Drug Trial. Biogen Stock Is Falling.

This could happen to Frequency Therapeutics.
Yes, but, the articles you provide talk about Alzheimer's research and drugs to cure that, as well as other brain diseases. Then the trial they discontinued was for a separate and rare brain disease they were also hoping to cure.

Similarly, Frequency Therapeutics is targeting mechanisms that could help aid a wide array of diseases, but the main focus is currently tinnitus.

Everything is speculation at this point.

What speaks to me is that they ran the first trial, and all the sudden a lot of additional money came out of the woodwork. I think investors had access to phase 1 results and now they really want to join.

Apparently we'll be let in on the results in a month or two.
 
Yes, but, the articles you provide talk about Alzheimer's research and drugs to cure that, as well as other brain diseases. Then the trial they discontinued was for a separate and rare brain disease they were also hoping to cure.

Similarly, Frequency Therapeutics is targeting mechanisms that could help aid a wide array of diseases, but the main focus is currently tinnitus.

Everything is speculation at this point.

What speaks to me is that they ran the first trial, and all the sudden a lot of additional money came out of the woodwork. I think investors had access to phase 1 results and now they really want to join.

Apparently we'll be let in on the results in a month or two
Just for clarification, the main thing they are trying to treat is hearing loss, not tinnitus.

The hope for us is that tinnitus will be treated as a result of treating hearing loss, but that is not their main objective.

It is true that a lot of money and new partners coming in doesn't guarantee that it will work, but it sure is a great sign that it probably will.

Now if it cures our tinnitus is another story, we just don't know for sure. I really hope it will, but no one knows for certain. Logic says it should help, as most of the science community agrees. But what is almost certain, if it does work, it'll help those that are currently ineligible for treatments like Lenire become eligible by having their hearing restored.
 
My mistake... "Hearing loss".

Again, at any rate, this entire conversation is speculatory until we cross the next milestones, therefore I'll bow out.

The ball is in our court though.
 
Even if it does not cure the tinnitus, at least I will have better hearing! Which will do wonders in masking my tinnitus.

And like @ChrisBoyMonkey said, those of us who aren't eligible to use Lenire because of hearing loss will be able to get the treatment in the future. I pray this drug is successful and that it comes out quickly.
 
I don't think the supporting cells would get hurt from cochlear damage like sound, as they do not react to it like hair cells do. It's like skin cells being able to be damaged by those levels of sound. And yes, those cells should be able to restore any frequency so long as they are hair cells.

Perhaps that's how they came up with their name...
Here is the publication from Frequency Therapeutics:

http://dx.doi.org/10.1016/j.celrep.2017.01.066.

I just had a quick read and think the paper says they can expand the number of positive supporting cells. So maybe even if you have some injury to your supporting cells, the drug can still work.
The reality is we don't know when there becomes too little supporting cells for this to work. But they suggest moderate hearing loss is the limit to FX-322's effective. Noise damages so many different things in the cochlea not just hair cells.
 
The reality is we don't know when there becomes too little supporting cells for this to work. But they suggest moderate hearing loss is the limit to FX-322's effective. Noise damages so many different things in the cochlea not just hair cells.
Oh, that's perfect. I have progressive hereditary hearing loss so by the time this comes out I probably won't have enough hearing for Frequency Therapeutics, either. Looks like both my tinnitus and hearing loss are here to stay :(. Nothing quite like having a whole bunch of new treatments for tinnitus for the first time ever, only to not be eligible for literally any of them. Staying optimistic is getting harder and harder...
 
Where did they say this?
I believe @Aaron123 posted the source along time ago about "moderate hearing loss being the therapeutic limit". It is somewhere in this thread multiple times.

I'll look for it.
 

Log in or register to get the full forum benefits!

Register

Register on Tinnitus Talk for free!

Register Now